Market Overview

Jim Cramer Advises His Viewers On Teva, AT&T And More

Related TEVA
Mid-Morning Market Update: Markets Edge Lower; Morgan Stanley Beats Q4 Estimates
Teva's Cost-Cutting Plan Nets A Mizuho Upgrade
U.S. Justice Department may seek damages from generic drugmakers for price-fixing (Seeking Alpha)
Related SGEN
42 Biggest Movers From Yesterday
30 Stocks Moving In Monday's Mid-Day Session

On CNBC's "Mad Money Lightning Round", Jim Cramer said that he'ss not crazy about Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA). He added that investors who really want to buy it, should wait for Allergan plc Ordinary Shares (NYSE: AGN) to sell its stake in the company.

Cramer thinks that Seattle Genetics, Inc. (NASDAQ: SGEN) should be bought.

Walgreens Boots Alliance Inc (NASDAQ: WBA) is going to trade lower, when, Inc. (NASDAQ: AMZN) enters its business, thinks Cramer. He is tempted, but he wouldn't buy it. He would wait.

Benchmark Electronics, Inc. (NYSE: BHE) has a lot of cool devices and manufacturing designs, said Cramer. He likes the stock and he would buy it, but he believes it isn't cheap.

Cramer isn't a buyer of Snap Inc (NYSE: SNAP). He would wait until all the sellers clean out.

With all the changes the company is making, AT&T Inc. (NYSE: T) is a buy, said Cramer.

Posted-In: mad money Lightning RoundCNBC Jim Cramer Media


Related Articles (AMZN + AGN)

View Comments and Join the Discussion!